2022 MMIT Patient Choice Awards Finalist
Senderra: Apr 29, 2022 5:12:52 PM
Senderra is a 2022 MMIT Patient Choice Awards Finalist!
Senderra is a 2022 MMIT Patient Choice Awards Finalist!
7th Annual MMIT Patient Choice Awards
Senderra is a finalist in the Managed Markets Insight & Technology (MMIT) seventh-annual Specialty Pharmacy Patient Choice Awards as ranked by patient satisfaction survey results from the previous year.
Each year, MMIT recognizes specialty pharmacies that provide best-in-class customer satisfaction and overall patient care.
2022 Award Finalist
Senderra is honored to be a finalist this year in the Independent Specialty Pharmacy category. This honor confirms Senderra’s ongoing commitment to keeping people first and providing exceptional patient care.
About senderra
Senderra is a national specialty pharmacy, serving patients with challenging and ongoing medical conditions through provision of specialty medications, clinical expertise and support services.
We dedicate ourselves to designing and executing a model to serve the needs of our patients and partners (Prescribers, Pharma and Payers) in order to make a difference and effect positive outcomes.
D2 Solutions and Senderra Specialty Pharmacy launch UltraTouch™
Senderra: Apr 28, 2022 1:58:59 PM
D2 Solutions and Senderra Specialty Pharmacy launch UltraTouch™, a network collaboration to improve market access for patient services for specialty...
Senderra Attends Forum At The US House Of Representatives
Senderra: Nov 18, 2021 10:55:31 AM
Senderra's Vice President Of Regulatory And Compliance, Tiffany Jones, attended a forum on the impact of pharmacy benefit managers (PBMs) in...